StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

MariMed's free cash flow for the twelve months ending Sep 30, 2026 was $9.13M, up 449.9% year over year. For fiscal 2025 it was $6.53M. The highest annual figure on record is $17.98M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.53M–
FY2024Dec 31, 2024-$5.18M–
FY2023Dec 31, 2023-$12.22M–
FY2022Dec 31, 2022-$4.83M-126.9%
FY2021Dec 31, 2021$17.98M–
FY2020Dec 31, 2020-$1.31M–
FY2019Dec 31, 2019-$33.81M–
FY2018Dec 31, 2018-$11.83M–
FY2017Dec 31, 2017-$19.21M–
FY2016Dec 31, 2016-$3.56M–
FY2014Dec 31, 2014-$452.56K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.24M+53.1%
Q2 FY2026Jun 30, 2026$1.92M–
Q1 FY2026Mar 31, 2026$576.00K-43.9%
Q4 FY2025Dec 31, 2025$3.40M–
Q3 FY2025Sep 30, 2025$2.12M–
Q2 FY2025Jun 30, 2025-$12.00K–
Q1 FY2025Mar 31, 2025$1.03M–
Q4 FY2024Dec 31, 2024-$1.47M–
Q3 FY2024Sep 30, 2024-$1.76M-191.0%
Q2 FY2024Jun 30, 2024-$1.78M–
Q1 FY2024Mar 31, 2024-$158.00K–
Q4 FY2023Dec 31, 2023-$2.15M–
Q3 FY2023Sep 30, 2023$1.94M+59.6%
Q2 FY2023Jun 30, 2023-$4.46M–
Q1 FY2023Mar 31, 2023-$7.55M-268.7%
Q4 FY2022Dec 31, 2022-$418.00K-109.5%
Q3 FY2022Sep 30, 2022$1.21M-72.7%
Q2 FY2022Jun 30, 2022-$10.10M-940.0%
Q1 FY2022Mar 31, 2022$4.48M–
Q4 FY2021Dec 31, 2021$4.38M–
Q1 FY2021Mar 31, 2021$4.45M–
Q4 FY2020Dec 31, 2020$1.20M–
Q3 FY2020Sep 30, 2020-$329.05K–
Q2 FY2020Jun 30, 2020-$410.52K–
Q1 FY2020Mar 31, 2020-$1.77M–
Q4 FY2019Dec 31, 2019-$2.88M–
Q3 FY2019Sep 30, 2019-$4.92M–
Q2 FY2019Jun 30, 2019-$18.24M–
Q1 FY2019Mar 31, 2019-$7.76M–
Q4 FY2018Dec 31, 2018-$3.03M–
Q3 FY2018Sep 30, 2018-$3.32M–
Q2 FY2018Jun 30, 2018-$3.31M–
Q1 FY2018Mar 31, 2018-$2.17M–
Q4 FY2017Dec 31, 2017-$10.34M-16717.2%
Q3 FY2017Sep 30, 2017-$5.15M–
Q2 FY2017Jun 30, 2017-$2.05M–
Q1 FY2017Mar 31, 2017-$1.67M–
Q4 FY2016Dec 31, 2016$62.21K–
Q3 FY2016Sep 30, 2016-$2.15M–

More MariMed figures

See a number that looks wrong?